1Kaikainen V, Ikaheimo R, Katila ML, et al. P fimbriation of Escherichia coli stains from patiens with urosepsis demonstrated by a commercialagg lulinations test[J].J Clin Microbiol,1991,29:221.
2鞠洪涛.大肠杆菌耐庆大霉素基因定位[D].解放军军需大学,1999,2-6.
3戴自英. 实用抗菌药物学(M).上海: 上海科技出版社,1989:268-275.
4Hiroaki Yoshida. Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli[J]. Antimicrobial Agents and Chemotherapy, June.1990,34(6):1271-1272.
5Claude J Soussy, John S Wolfson, Eva Y NG. Limitations of plasmid complementation test for determination of quinolone resistance due to changes in the gyrase A protein and identification of conditional quinolone resistance locus[J]. Antimicrobial Agents And Chemotherapy,Dec.1993,37(12):2588-2592.
6Piddock LJ. Mechanisms of fluoroquinolone resistance: an update 1994-1998[J].Drugs,1999,58 (2):11-18.
7Jordi Vila, Joaquim Ruiz, Francesc Marco, et al. Association between double mutation in gyra gene of ciprofloxacin-resistant clinical isolates of Escherichia coli and MICs[J]. Antimicrobial Agents and Chemotherapy,1994,38(10):2477-2479.
8Hiroaki Yoshida. Quinolone Resistance-determining region in the DNA Gyrase gyrB gene of Escherichia coli[J]. Antimicrobial Agents and Chemotherapy.1991,35(8):1647-1650.
9Kumagai,Y.Quinolone-resistant mutants of Escherichia coli DNA topoisomerase IV parC gene,[J].Antimicrobial Agents and Chemotherapy. 1996,40(3):710-714.
10Jordi Vila. Detection of Mutations in parC in quinolone- resistant clinical isolates of Escherichia coli[J]. Antimicrobial Agents and Chemotherapy,1996,40(2):491-493.
